NYSEArca - Delayed Quote USD

Virtus LifeSci Biotech Products ETF (BBP)

52.07 +0.58 (+1.13%)
At close: April 25 at 11:35 AM EDT

ETF Summary

Under normal market conditions, the fund will invest not less than 80% of its assets in component securities of the index. The index seeks to track the performance of the common stock of U.S. exchange-listed biotechnology companies with at least one drug therapy approved by the U.S. Food and Drug Administration ("FDA") for marketing.

ETF Overview

Category Health
Fund Family Virtus
Net Assets 19.84M
YTD Daily Total Return -10.37%
Yield 0.00%
Legal Type Exchange Traded Fund

ETF Operations

Attributes BBP Category Average
Annual Report Expense Ratio (net) 0.79% 1.01%
Holdings Turnover 49.00% 51.04%
Total Net Assets 4,803.05 4,803.05

Morningstar Style Box

Yahoo partners with Morningstar a leading market research and investment data group to help investors rate and compare funds on Yahoo Finance. The Morningstar Category is shown next to the Morningstar Style Box which identifies a fund's investment focus, based on the underlying securities in the fund. MORNING_STAR_STYLE_BOX

Morningstar Category

While the investment objective stated in a fund's prospectus may or may not reflect how the fund actually invests, the Morningstar category is assigned based on the underlying securities in each portfolio. Morningstar categories help investors and investment professionals make meaningful comparisons between funds. The categories make it easier to build well-diversified portfolios, assess potential risk, and identify top-performing funds. We place funds in a given category based on their portfolio statistics and compositions over the past three years. If the fund is new and has no portfolio history, we estimate where it will fall before giving it a more permanent category assignment. When necessary, we may change a category assignment based on recent changes to the portfolio.

Related Tickers